Since WIP and WIRE are both expressed strongly in BCC and are involved in efficient invasion by MDA-MB-231 cells, we tested whether WIP/WIRE expression is controlled by a compensatory mechanism. The gene discussed is WIPF2; the disease is skin basal cell carcinoma.